122 related articles for article (PubMed ID: 22635240)
1. Antiphospholipid syndrome in northwest Italy (APS Piedmont Cohort): demographic features, risk factors, clinical and laboratory profile.
Bertero MT; Bazzan M; Carignola R; Montaruli B; Silvestro E; Sciascia S; Vaccarino A; Baldovino S; Roccatello D;
Lupus; 2012 Jun; 21(7):806-9. PubMed ID: 22635240
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the 2006 revised antiphospholipid syndrome classification criteria.
Kaul M; Erkan D; Sammaritano L; Lockshin MD
Ann Rheum Dis; 2007 Jul; 66(7):927-30. PubMed ID: 17337473
[TBL] [Abstract][Full Text] [Related]
3. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study.
Ruffatti A; Tonello M; Visentin MS; Bontadi A; Hoxha A; De Carolis S; Botta A; Salvi S; Nuzzo M; Rovere-Querini P; Canti V; Mosca M; Mitic G; Bertero MT; Pengo V; Boffa MC; Tincani A
Rheumatology (Oxford); 2011 Sep; 50(9):1684-9. PubMed ID: 21652586
[TBL] [Abstract][Full Text] [Related]
5. Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients.
Cervera R; Khamashta MA; Shoenfeld Y; Camps MT; Jacobsen S; Kiss E; Zeher MM; Tincani A; Kontopoulou-Griva I; Galeazzi M; Bellisai F; Meroni PL; Derksen RH; de Groot PG; Gromnica-Ihle E; Baleva M; Mosca M; Bombardieri S; Houssiau F; Gris JC; Quéré I; Hachulla E; Vasconcelos C; Roch B; Fernández-Nebro A; Piette JC; Espinosa G; Bucciarelli S; Pisoni CN; Bertolaccini ML; Boffa MC; Hughes GR;
Ann Rheum Dis; 2009 Sep; 68(9):1428-32. PubMed ID: 18801761
[TBL] [Abstract][Full Text] [Related]
6. Clinical manifestations of antiphospholipid syndrome (APS) with and without antiphospholipid antibodies (the so-called 'seronegative APS').
Rodriguez-Garcia JL; Bertolaccini ML; Cuadrado MJ; Sanna G; Ateka-Barrutia O; Khamashta MA
Ann Rheum Dis; 2012 Feb; 71(2):242-4. PubMed ID: 21953349
[TBL] [Abstract][Full Text] [Related]
7. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
8. Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome.
Lopez LR; Dier KJ; Lopez D; Merrill JT; Fink CA
Am J Clin Pathol; 2004 Jan; 121(1):142-9. PubMed ID: 14750252
[TBL] [Abstract][Full Text] [Related]
9. Hospital based prospective longitudinal clinical and immunologic study of 179 patients of primary anti-phospholipid syndrome.
Singh NK; Behera DR; Agrawal A; Singh MN; Kumar V; Godhra M; Gupta A; Yadav DP; Singh U; Pandey LK; Matah M
Int J Rheum Dis; 2013 Oct; 16(5):547-55. PubMed ID: 24164842
[TBL] [Abstract][Full Text] [Related]
10. Patients with antiphosholipid syndrome and thrombotic recurrences: A real world observation (the Piedmont cohort study).
Bazzan M; Vaccarino A; Stella S; Sciascia S; Montaruli B; Bertero MT; Carignola R; Roccatello D;
Lupus; 2016 Apr; 25(5):479-85. PubMed ID: 26657216
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.
Muñoz-Rodríguez FJ; Reverter JC; Font J; Tàssies D; Cervera R; Espinosa G; Carmona F; Balasch J; Ordinas A; Ingelmo M
Haematologica; 2000 Jun; 85(6):632-7. PubMed ID: 10870121
[TBL] [Abstract][Full Text] [Related]
12. [Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome].
Reshetniak TM; Seredavkina nV; Mach ES; Aleksandrova EN; Novikov AA; Cherkasova MV; Nasonov EL
Ter Arkh; 2008; 80(10):60-7. PubMed ID: 19105418
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
Musial J; Swadzba J; Motyl A; Iwaniec T
J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
[TBL] [Abstract][Full Text] [Related]
14. Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals.
Girón-González JA; García del Río E; Rodríguez C; Rodríguez-Martorell J; Serrano A
J Rheumatol; 2004 Aug; 31(8):1560-7. PubMed ID: 15290736
[TBL] [Abstract][Full Text] [Related]
15. Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry.
Avcin T; Cimaz R; Silverman ED; Cervera R; Gattorno M; Garay S; Berkun Y; Sztajnbok FR; Silva CA; Campos LM; Saad-Magalhaes C; Rigante D; Ravelli A; Martini A; Rozman B; Meroni PL
Pediatrics; 2008 Nov; 122(5):e1100-7. PubMed ID: 18955411
[TBL] [Abstract][Full Text] [Related]
16. Obstetric antiphospholipid syndrome: still a challenge.
Levy RA; Jesús GR; Jesús NR
Lupus; 2010 Apr; 19(4):457-9. PubMed ID: 20353988
[TBL] [Abstract][Full Text] [Related]
17. Antiphospholipid syndrome in Mexican children.
Zamora-Ustaran A; Escarcega-Alarcón RO; Garcia-Carrasco M; Faugier E; Mendieta-Zeron S; Mendoza-Pinto C; Montiel-Jarquin A; Muñoz-Guarneros M; Lopez-Colombo A; Cervera R
Isr Med Assoc J; 2012 May; 14(5):286-9. PubMed ID: 22799058
[TBL] [Abstract][Full Text] [Related]
18. A study of 75 pregnancies in patients with antiphospholipid syndrome.
Huong DL; Wechsler B; Bletry O; Vauthier-Brouzes D; Lefebvre G; Piette JC
J Rheumatol; 2001 Sep; 28(9):2025-30. PubMed ID: 11550970
[TBL] [Abstract][Full Text] [Related]
19. Thrombotic events during long-term follow-up of obstetric antiphospholipid syndrome patients.
Lefèvre G; Lambert M; Bacri JL; Dubucquoi S; Quemeneur T; Caron C; Launay D; Houfflin-Debarge V; Hachulla E; Kyndt X; Subtil D; Hatron PY
Lupus; 2011 Jul; 20(8):861-5. PubMed ID: 21546412
[TBL] [Abstract][Full Text] [Related]
20. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
